Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
Result Page   
Add Marked to Bag Add All On Page
Num Mark Titles (201-250 of 337) Year Entries
371 Found
201 Guidance for industry [electronic resource] : pharmacovigilance of veterinary medicinal products, ma   2006 1
202 Guidance for industry [electronic resource] : pharmacovigilance of veterinary medicinal products : m   2001 1
203 Guidance for industry [electronic resource] : photosafety testing.   2003 1
204 Guidance for industry [electronic resource] : population pharmacokinetics.   1999 1
205 Guidance for industry [electronic resource] : possible dioxin/PCB contamination of drug and biologic   1999 1
206 Guidance for industry [electronic resource] : potassium chloride modified-release tablets and capsul   2005 1
207 Guidance for industry [electronic resource] : potency tests for cellular and gene therapy products.   2008 1
208 Guidance for industry [electronic resource] : pre-approval information for registration of new veter   2004 1
209 Guidance for industry [electronic resource] : pre-storage leukocyte reduction of whole blood and blo   2001 1
210 Guidance for industry [electronic resource] : precautionary measures to reduce the possible risk of   2
211 Guidance for industry [electronic resource] : premarketing risk assessment.   2005 1
212 Guidance for industry [electronic resource] : preparation of IDEs and INDs for products intended to   2007 1
213 Guidance for industry [electronic resource] : Prescription Drug Marketing Act, donation of prescript   2006 1
214 Guidance for industry [electronic resource] : Prescription Drug Marketing Act (PDMA) requirements, q   2006 1
215 Guidance for industry [electronic resource] : presenting risk information in prescription drug and m   2009 1
216 Guidance for industry [electronic resource] : process validation, general principles and practices.   2008 1
217 Guidance for industry [electronic resource] : protecting the rights, safety and welfare of study sub   2007 1
218 Guidance for industry [electronic resource] : providing clinical evidence of effectiveness for human   1998 1
219 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2005 1
220 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2
221 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2003 1
222 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format   2
223 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2008 1
224 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2001 1
225 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2007 1
226 Guidance for industry [electronic resource] : providing regulatory submissions to CBER in electronic   2002 1
227 Guidance for industry [electronic resource] : providing regulatory submissions to the Center for Bio   2007 1
228 Guidance for industry [electronic resource] : public health issues posed by the use of nonhuman prim   1999 1
229 Guidance for industry [electronic resource] : Q10 pharmaceutical quality system.   2009 1
230 Guidance for industry [electronic resource] : Q1A(R2) stability testing of new drug substances and p   2003 1
231 Guidance for industry [electronic resource] : Q1B photostability testing of new drug substances and   1996 1
232 Guidance for industry [electronic resource] : Q1C stability testing for new dosage forms.   1996 1
233 Guidance for industry [electronic resource] : Q1D bracketing and matrixing designs for stability tes   2003 1
234 Guidance for industry [electronic resource] : Q1E evaluation of stability data.   2004 1
235 Guidance for industry [electronic resource] : Q2B validation of analytical procedures, methodology.   1996 1
236 Guidance for industry [electronic resource] : Q3A impurities in new drug substances.   2
237 Guidance for industry [electronic resource] : Q3B(R2) impurities in new drug products.   2006 1
238 Guidance for industry [electronic resource] : Q3C impurities, residual solvents.   1997 1
239 Guidance for industry [electronic resource] : Q3C tables and list.   2003 1
240 Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial te   9
241 Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmocopoeial te   2009 1
242 Guidance for industry [electronic resource] : Q5A viral safety evaluation of biotechnology products   1998 1
243 Guidance for industry [electronic resource] : Q5E comparability of biotechnological/biological produ   2005 1
244 Guidance for industry [electronic resource] : Q6B specifications : test procedures and acceptance cr   1999 1
245 Guidance for industry [electronic resource] : Q7A good manufacturing practice guidance for active ph   2001 1
246 Guidance for industry [electronic resource] : Q8 pharmaceutical development.   2006 1
247 Guidance for industry [electronic resource] : Q8(R2) pharmaceutical development.   2009 1
248 Guidance for industry [electronic resource] : Q9 quality risk management.   2006 1
249 Guidance for industry [electronic resource] : qualifying for pediatric exclusivity under section 505   1999 1
250 Guidance for industry [electronic resource] : quality systems approach to pharmaceutical CGMP regula   2006 1
Add Marked to Bag Add All On Page
Locate in results
Result Page   
 
    
Available items only